Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Understanding and treating the inflammatory adverse events of cancer immunotherapy

Cell(2021)10.1016/j.cell.2021.02.011Source: DataRank Database

Understanding and treating the inflammatory adverse events of cancer immunotherapy is a research paper published in Cell (2021). On theSindex it has a DataRank of 0. It has been cited 304 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access304 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 16.05)OA: bronzeTopics (32)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Adrienne Luoma ORCID,Stephanie K. Dougan ORCID,Kai W. Wucherpfennig ORCID,Michael Dougan ORCID

Live enrichment

PubMed:33675691 OpenAlex:https://openalex.org/W3134238388

NCI NIH HHS

Grant: P01 CA163222

NIDDK NIH HHS

Grant: K08 DK114563

NCI NIH HHS

Grant: T32 CA207021

NCI NIH HHS

Grant: R01 CA238039

NCI NIH HHS

Grant: R01 CA251599

FWCI

16.05

Citation Percentile

1.0%

Citation Trend

2015

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S0092867421001616/pdf

publisherhttp://www.cell.com/article/S0092867421001616/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867421001616?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421001616?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2021.02.011

Fields of Study

Cancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmune Cell Function and InteractionAnimalsCytokinesHumansImmune Checkpoint InhibitorsImmunotherapyInflammationNeoplasmsT-Lymphocytes

MeSH Terms

Immune Checkpoint InhibitorsAnimalsHumansImmunotherapyInflammationNeoplasmsT-LymphocytesCytokines

Keywords

ImmunotherapyAdverse effectBiologyCancerCancer immunotherapyChimeric antigen receptorImmune systemImmunologyBlockadeFood and drug administrationBioinformaticsPharmacologyReceptor

Sustainable Development Goals

SDG 0: Good health and well-being